FDA AdCom overwhelmingly supports accelerated approval for Biogen’s tofersen in ALS
AdCom panelists backed an accelerated approval for Biogen’s tofersen in a rare form of ALS based on a new surrogate biomarker.
Managed access programmes: expanding clinical development plans for patients in need
Pipeline Moves: advancement prospects jump for Parkinson’s disease stem cell therapy
Rett syndrome: How does Acadia’s trofinetide compare to ANAVEX2-73?
Sustainability and tech at the forefront of clinical trial supply chains
Duchenne muscular dystrophy: major trials and events to watch in 2023
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreSyneos Health and KX partner for data-driven insights
The collaboration will deliver data-driven predictive analytics, AI and ML capabilities for customers.
More themes
Insights
View MoreWho’s hiring who? Hiring activity related to social responsibility increased by 10% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
Cloudbyz launches new electronic data capture platform for clinical trials
Atea Pharmaceuticals announces results of bemnifosbuvir for Covid-19
Clario launches comprehensive clinical trial solution
BWH’s investigators test Foralumab in pilot trial for Covid-19